Phase 3 Type 2 Diabetes Clinical Trials
27 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 27 trials
Recruiting
Phase 3
A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity or OverweightType 2 Diabetes Mellitus
Hoffmann-La Roche1,600 enrolled3 locationsNCT07351058
Recruiting
Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
ObesityOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Hudson Biotech2,539 enrolled1 locationNCT07481747
Recruiting
Phase 3
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Type 2 Diabetes (Adult Onset)
The University of Texas Health Science Center at San Antonio256 enrolled2 locationsNCT06246799
Recruiting
Phase 3
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Type 2 Diabetes (T2DM)LipidemiaMetabolic Syndrome (MetS)
NewAmsterdam Pharma300 enrolled20 locationsNCT07219602
Recruiting
Phase 3
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Type 2 DiabetesDementia, MildMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School420 enrolled8 locationsNCT07083154
Recruiting
Phase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Eli Lilly and Company55 enrolled51 locationsNCT06739122
Recruiting
Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
ObesityOverweightType 2 Diabetes
Eli Lilly and Company1,200 enrolled80 locationsNCT06993792
Recruiting
Phase 3
A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.240 enrolled1 locationNCT07394114
Recruiting
Phase 3
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Chronic Kidney DiseasesType 2 Diabetes Mellitus
Prokidney685 enrolled86 locationsNCT05099770
Recruiting
Phase 3
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Type 2 Diabetes
Novo Nordisk A/S264 enrolled15 locationsNCT07271251
Recruiting
Phase 3
Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07060456
Recruiting
Phase 3
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
Type 2 Diabetes Mellitus
EMS270 enrolled1 locationNCT04670666
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
ObesityOverweightType 2 Diabetes
Eli Lilly and Company600 enrolled77 locationsNCT06972472
Recruiting
Phase 3
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.477 enrolled4 locationsNCT07064486
Recruiting
Phase 3
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.360 enrolled1 locationNCT07193459
Recruiting
Phase 3
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
HypertensionType 2 Diabetes
THPharm Corp.221 enrolled2 locationsNCT06647745
Recruiting
Phase 3
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.800 enrolled1 locationNCT07082114
Recruiting
Phase 3
Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery
Bariatric SurgeryType 2 Diabetes
Assistance Publique - Hôpitaux de Paris54 enrolled1 locationNCT06192693
Recruiting
Phase 3
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University1,000 enrolled1 locationNCT06825182